Skip to search formSkip to main contentSkip to account menu

moxonidine

Known as: 4-Chloro-5-(2-Imidazolidinyldeneamino)-6-Methoxy-2-Methylpyrimidine, 4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine, moxonidin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
The great British-American scientist-philosopher Alfred North Whitehead divided progress into three stages, the second of which… 
Highly Cited
2001
Highly Cited
2001
We present a mechanism for agonist-promoted alpha(2A)-adrenergic receptor (alpha(2A)-AR) activation based on structural… 
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To study whether insulin sensitivity and insulin response are altered by moxonidine treatment in obese patients with… 
Highly Cited
1998
Highly Cited
1998
Deriving a population pharmacokinetic model from real data is always associated with numerous assumptions. Violations of these… 
Highly Cited
1996
Highly Cited
1996
1. With the use of whole‐cell patch clamp recordings in slices of guinea‐pig substantia gelatinosa (SG), we studied the serotonin… 
Highly Cited
1996
Highly Cited
1996
BACKGROUND Experimental renal failure causes structural alterations of the kidney. It is still unresolved how these changes are… 
Highly Cited
1995
Highly Cited
1995
Noradrenergic involvement in the discriminative stimulus (DS) effects of cocaine was investigated in squirrel monkeys by using a… 
Highly Cited
1994
Highly Cited
1994
The rostral ventrolateral medulla (RVLM) is the primary region maintaining vasomotor tone, and a site of action for central… 
Highly Cited
1993
Highly Cited
1993
Both the hypotension and the sedation elicited by centrally acting antihypertensive agents are traditionally attributed to…